English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Prostate cancer (PC) is the most frequently diagnosed cancer in men. The acquisition of castration-resistant (CR) phenotype is associated with the activation of signaling pathways mediated by growth factors. The TGFβ1 and its receptors have an important role in tumor progression, being the pro-apoptotic function modulated by the expression of  TGFBR2 . A single nucleotide polymorphism -875 G > A in  TGFBR2  gene has been described, which may influence the expression levels of the receptor. Our purpose was to investigate the potential role of  TGFBR2-875G>A  in PC risk and in the response to androgen deprivation therapy (ADT).  TGFBR2-875G>A  polymorphism was studied by allelic discrimination using real-time polymerase chain reaction (PCR) in 891 patients with PC and 874 controls. A follow-up study was undertaken to evaluate response to ADT. The  TGFBR2  and  SMAD7  mRNA expression were analyzed by a quantitative real-time PCR. We found that  TGFBR2-875GG  homozygous patients present lower expression levels of  TGFBR2  mRNA ( AA/AG : 2 -ΔΔCT  =1.5,  P =0.016). GG genotype was also associated with higher Gleason grade (OR=1.51,  P =0.019) and increased risk of an early relapse after ADT (HR=1.47,  P =0.024). The concordance (c) index analysis showed that the definition of profiles that contains information regarding tumor characteristics associated with genetic information present an increased capacity to predict the risk for CR development (c-index model 1: 0.683  vs  model 2: 0.736  vs  model 3: 0.746  vs  model 4: 0.759). The  TGFBR2-875G>A  contribution to an early relapse in ADT patients, due to changes in mRNA expression, supports the involvement of TGFβ1 pathway in CRPC. Furthermore, according to our results, we hypothesize the potential benefits of the association of genetic information in predictive models of CR development.

Improvement of a Predictive Model of Castration-Resistant Prostate Cancer: Functional Genetic Variants in TGFβ1 Signaling Pathway Modulation